Phase IThyroid Analog
Compound 61590
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061590
Risk Class
LOW
Last Audit
Apr 25, 2108
Research Abstract
Thyroid Analog candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61590 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase i with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061590 with updates logged 2108-04-25.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61590Thyroid Analog Program 61590
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061590
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61590